Apr 28, 2009 | Circulation
[Original Contributions] Candesartan Augments Ischemia-Induced...
From the Program in Clinical and Experimental Therapeutics , University of Georgia College of Pharmacy, Veterans Administration Medical Center, Augusta, Ga; and the Departments of Physiology Biostatistics , Medical College of Georgia, Augusta Ga.
Angiotensin II receptor blocker-based vs. non-angiotensin II receptor ...
Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease Eur Heart J , ehp101.
Supramaximal Dose of Candesartan in Proteinuric Renal Disease.
Abstract High levels of proteinuria predict renal deterioration, suggesting that interventions to reduce proteinuria may postpone the development of severe renal impairment.
Optimal dose of candesartan for renoprotection in type 2 diabetic...
Abstract OBJECTIVE: We evaluated the optimal dose of the angiotensin II receptor antagonist candesartan cilexetil for renoprotection as reflected by short-term changes in albuminuria in hypertensive type 2 ...
[Article] Candesartan Augments Ischemia-Induced Proangiogenic State...
Azza B. El-Remessy RPh, PhD; Maribeth H. Johnson MS; Livia S. Machado BPharm; Hazem F. Elewa RPh; Mohammed Abdelsaid MS; Daniel C. Wiley BS; and Susan C. Fagan PharmD* From the Program in Clinical and ...
China Pharma Looks to Expand Generic Portfolio with Hypertension Drug
China Pharma Holdings, Inc. has begun a clinical trial of a generic version of the hypertension drug Candesartan.
GenoMed's Results Supported by Canadian Study: Dose is Key
February 12, 2009 - GenoMed announced today that AstraZeneca's study showing that high dose Atacand was better than low dose drug for patients with kidney failure fully supports results its CEO observed 15 ...
Hypertension drug dramatically reduces proteinuria in kidney disease patients
Taking a much higher than recommended dose of the hypertension drug candesartan cilexetil effectively lowered the amount of protein excreted in the urine of patients with kidney disease, according to a study ...
Blood pressure drug helps kidney patients - study
Large doses of AstraZeneca's high blood pressure drug Atacand may protect people with kidney disease from developing kidney failure and the need for dialysis or a transplant, researchers said Wednesday.
China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
Company initiated clinical trials for leading hypertension drug in China a a HAIKOU CITY, China, Feb.
AstraZeneca Secures Approval for Two New Dosage Strengths of Atacand Plus
The decentralised procedure - including eleven EU member states and Iceland, and with Sweden as reference member state - ended positively, and national approvals will follow.
[Original Articles] Plasma Kallikrein Mediates Angiotensin II Type 1...
From the Department of Medicine , Harvard Medical School, Research Division, Joslin Diabetes Center, Boston, Mass; ActiveSite Pharmaceuticals, Inc , San Francisco, Calif; and Telehealth Research Institute , ...
New Drug Application Approval for Ecard HD and Ecard LD in Japan
ECARD is a tablet taken orally once daily and the two approved formulations are "ECARD LD" and "ECARD HD"; 4mg candesartan cilexetil / 6.25mg hydrochlorothiazide and 8mg candesartan cilexetil / 6.25mg ...
[Scientific Contribution] Plasma Kallikrein Mediates Angiotensin II...
From the Department of Medicine , Harvard Medical School, Research Division, Joslin Diabetes Center, Boston, Mass; ActiveSite Pharmaceuticals, Inc , San Francisco, Calif; and Telehealth Research Institute , ...
Safe New Therapy For Genetic Heart Disease
Main Category: Heart Disease Also Included In: Genetics Article Date: 02 Jan 2009 - 3:00 PST A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may ...
Safe new therapy for genetic heart disease
A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease.
Angiotensin II receptor blockers
Angiotensin II receptor blockers are used to treat conditions such as high blood pressure and heart failure.
Candesartan Investigated in Hypotensive Patients
Among heart failure patients with low ejection fraction and low systolic blood pressure, treatment with candesartan is still efficacious, according to the results of a clinical study reported in the Dec.